Author Surname Correction

In the Letter to the Editor titled “Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction in Patients With Chronic Immune-Mediated Inflammatory Diseases,” published in the September 21, 2021, issue of JAMA,¹ the first author’s surname should have been listed as “Papamichael.” This article was corrected online.